International Journal of Genomics (Jan 2024)

Pan-Cancer Analysis Reveals PRIM2 as a Potential Biomarker for Diagnosis, Prognosis, and Immunomodulatory

  • Xi Zhang,
  • Yuanyu Zhang,
  • Leheng Liu,
  • Zheng Gong,
  • Kecheng Zhou

DOI
https://doi.org/10.1155/2024/8834415
Journal volume & issue
Vol. 2024

Abstract

Read online

Conclusion: This research highlights the potential of PRIM2 as a biomarker for cancer diagnosis and prognosis, and as a target for immunomodulatory therapy, offering valuable insights for clinical applications.